Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2022-06-24 Sale |
2022-06-28 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Kewalramani Reshma CEO & President |
11,689 | $291.3 | $3,405,006 | 111,153 (Direct) |
View |
2022-05-16 Sale |
2022-05-18 4:22 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
45 | $252.83 | $11,377 | 41,749 (Direct) |
View |
2022-05-16 Sale |
2022-05-18 4:21 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
133 | $251.19 | $33,408 | 64,900 (Indirect Direct) |
View |
2022-05-16 Sale |
2022-05-18 4:18 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Liu Joy SVP, General Counsel |
133 | $252.88 | $33,633 | 14,334 (Direct) |
View |
2022-05-04 Sale |
2022-05-06 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
36 | $275.09 | $9,903 | 41,660 (Direct) |
View |
2022-05-02 Sale |
2022-05-04 5:21 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Arbuckle Stuart A EVP, COO |
306 | $263.98 | $80,778 | 64,900 (Indirect Direct) |
View |
2022-05-02 Sale |
2022-05-04 5:10 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
320 | $259.16 | $82,930 | 41,696 (Direct) |
View |
2022-05-02 Sale |
2022-05-04 5:09 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
737 | $258.94 | $190,842 | 5,903 (Direct) |
View |
2022-05-02 Sale |
2022-05-04 5:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
343 | $258.83 | $88,778 | 42,730 (Direct) |
View |
2022-05-01 Sale |
2022-05-03 4:48 pm |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
1,842 | $0 | $0 | 5,822 (Indirect Direct) |
View |
2022-05-01 Sale |
2022-05-03 4:47 pm |
VERTEX PHARMACEUTICALS INC | VRTX | MCGLYNN MARGARET G Director |
921 | $0 | $0 | 10,249 (Direct) |
View |
2022-04-29 Sale |
2022-05-03 4:28 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Liu Joy SVP, General Counsel |
120 | $275.41 | $33,049 | 14,334 (Direct) |
View |
2022-04-25 Sale |
2022-04-27 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Ambrose Kristen SVP & Chief Accounting Officer |
327 | $269.55 | $88,143 | 3,496 (Direct) |
View |
2022-04-18 Sale |
2022-04-20 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Lee Yuchun Director |
2,000 | $284.23 | $568,467 | 1,875 (Direct) |
View |
2022-04-14 Sale |
2022-04-18 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Lee Yuchun Director |
2,000 | $289.06 | $578,117 | 3,875 (Direct) |
View |
2022-04-13 Sale |
2022-04-14 4:35 pm |
VERTEX PHARMACEUTICALS INC | VRTX | LEIDEN JEFFREY M Executive Chairman |
15,789 | $289.04 | $4,563,653 | 74,600 (Indirect Direct) |
View |
2022-04-12 Sale |
2022-04-14 4:35 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Lee Yuchun Director |
4,000 | $284.27 | $1,137,060 | 11,875 (Direct) |
View |
2022-04-08 Sale |
2022-04-12 4:07 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Lee Yuchun Director |
4,000 | $279.43 | $1,117,740 | 19,875 (Direct) |
View |
2022-04-08 Sale |
2022-04-12 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
1,907 | $280.2 | $534,341 | 5,191 (Direct) |
View |
2022-04-08 Sale |
2022-04-12 4:05 pm |
VERTEX PHARMACEUTICALS INC | VRTX | MCGLYNN MARGARET G Director |
5,000 | $280.22 | $1,401,080 | 6,099 (Direct) |
View |
2022-04-06 Sale |
2022-04-08 5:57 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Lee Yuchun Director |
4,000 | $273.24 | $1,092,964 | 27,875 (Direct) |
View |
2022-04-07 Sale |
2022-04-08 4:34 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
561 | $276.18 | $154,935 | 42,782 (Direct) |
View |
2022-04-04 Sale |
2022-04-06 5:02 pm |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
3,725 | $274.1 | $1,021,005 | 43,343 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2022-07-15 Option Award |
2022-07-19 4:35 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
151 | $289.23 | 13,975 (Direct) |
View |
2022-07-15 Option Award |
2022-07-19 4:33 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
95 | $289.23 | 2,826 (Direct) |
View |
2022-07-15 Option Award |
2022-07-19 4:32 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Upadhyay Suketu Director |
42 | $289.23 | 42 (Direct) |
View |
2022-05-31 Tax Withholding |
2022-06-02 4:06 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bozic Carmen EVP and CMO |
311 | $271.24 | 49,512 (Direct) |
View |
2022-05-18 Option Award |
2022-05-19 4:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Upadhyay Suketu Director |
1,558 | $0 | 1,558 (Direct) |
View |
2022-05-01 Option Award |
2022-05-03 5:41 pm |
2022-05-01 2032-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | Kearney Terrence C Director |
2,956 | $0 | 8,767 (Direct) |
View |
2022-05-01 Option Award |
2022-05-03 4:53 pm |
2022-05-01 2032-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | Lee Yuchun Director |
4,462 | $0 | 4,462 (Direct) |
View |
2022-05-01 Option Award |
2022-05-03 4:48 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
3,291 | $0 | 5,822 (Direct) |
View |
2022-05-01 Option Award |
2022-05-03 4:47 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
1,449 | $0 | 6,640 (Direct) |
View |
2022-05-01 Option Award |
2022-05-03 4:47 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCGLYNN MARGARET G Director |
5,383 | $0 | 10,249 (Direct) |
View |
2022-05-01 Option Award |
2022-05-03 4:44 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | CARNEY LLOYD Director |
1,449 | $0 | 6,850 (Direct) |
View |
2022-05-01 Option Award |
2022-05-03 4:43 pm |
2022-05-01 2032-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
4,462 | $0 | 4,462 (Direct) |
View |
2022-05-01 Option Award |
2022-05-03 4:42 pm |
2022-05-01 2032-04-30 |
VERTEX PHARMACEUTICALS INC | VRTX | Garber Alan M Director |
4,462 | $0 | 4,462 (Direct) |
View |
2022-04-29 Tax Withholding |
2022-05-03 4:27 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | WAGNER CHARLES F JR EVP & Chief Financial Officer |
547 | $276.17 | 43,073 (Direct) |
View |
2022-04-29 Tax Withholding |
2022-05-03 4:26 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Sanna Bastiano EVP, Cell & Genetic Therapies |
766 | $276.17 | 42,016 (Direct) |
View |
2022-04-18 Exercise |
2022-04-20 4:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Lee Yuchun Director |
2,000 | $81.54 | 1,875 (Direct) |
View |
2022-04-18 Exercise |
2022-04-20 4:05 pm |
N/A 2023-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | Lee Yuchun Director |
2,000 | $0 | 1,875 (Direct) |
View |
2022-04-14 Exercise |
2022-04-18 4:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Lee Yuchun Director |
2,000 | $81.54 | 3,875 (Direct) |
View |
2022-04-14 Exercise |
2022-04-18 4:05 pm |
N/A 2023-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | Lee Yuchun Director |
2,000 | $0 | 3,875 (Direct) |
View |
2022-04-14 Option Award |
2022-04-18 4:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCKENZIE DIANA Director |
95 | $289.41 | 889 (Direct) |
View |
2022-04-14 Option Award |
2022-04-18 4:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | SACHS BRUCE I Director |
151 | $289.41 | 13,824 (Direct) |
View |
2022-04-12 Exercise |
2022-04-14 4:35 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Lee Yuchun Director |
4,000 | $81.54 | 11,875 (Direct) |
View |
2022-04-12 Exercise |
2022-04-14 4:35 pm |
N/A 2023-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | Lee Yuchun Director |
4,000 | $0 | 11,875 (Direct) |
View |
2022-04-08 Exercise |
2022-04-12 4:07 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Lee Yuchun Director |
4,000 | $81.54 | 19,875 (Direct) |
View |
2022-04-08 Exercise |
2022-04-12 4:07 pm |
N/A 2023-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | Lee Yuchun Director |
4,000 | $0 | 19,875 (Direct) |
View |
2022-04-08 Exercise |
2022-04-12 4:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
1,907 | $125.71 | 5,191 (Direct) |
View |
2022-04-08 Exercise |
2022-04-12 4:05 pm |
N/A 2027-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | Bhatia Sangeeta N. Director |
1,907 | $0 | 5,191 (Direct) |
View |
2022-04-08 Exercise |
2022-04-12 4:05 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | MCGLYNN MARGARET G Director |
5,000 | $127.54 | 6,099 (Direct) |
View |
2022-04-08 Exercise |
2022-04-12 4:05 pm |
N/A 2025-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | MCGLYNN MARGARET G Director |
5,000 | $0 | 6,099 (Direct) |
View |
2022-04-06 Exercise |
2022-04-08 5:57 pm |
N/A N/A |
VERTEX PHARMACEUTICALS INC | VRTX | Lee Yuchun Director |
4,000 | $81.54 | 27,875 (Direct) |
View |
2022-04-06 Exercise |
2022-04-08 5:57 pm |
N/A 2023-05-31 |
VERTEX PHARMACEUTICALS INC | VRTX | Lee Yuchun Director |
4,000 | $0 | 27,875 (Direct) |
View |